Analysis of Spontaneous Reports as a Methodological Pharmacovigilance Tool-Reference-Cited by-同舟云学术

Analysis of Spontaneous Reports as a Methodological Pharmacovigilance Tool

Published:2022-06-10 Issue:2 Volume:18 Page:40-45
ISSN:2713-0428
Container-title:Journal Biomed
language:
Short-container-title:BIOMEDICINE

Author:

Litvinenko T. S.¹,Safronenko A. V.¹,Maklyakov Yu. S.¹,Gantsgorn E. V.¹,Postnikova E. S.¹,Gaisaev M. O.¹,Brizhak V. G.¹

Affiliation:

1. Rostov State Medical University of the Ministry of Health Care of Russia

Abstract

This article deals with the problem of undesirable drug reactions (UDR), having particular importance for both pharmacology and the healthcare system as a whole. Up-to-date information on the global prevalence of UDR is presented. A methodological approach to monitoring UDR based on a system of spontaneous reporting (SR) is proposed. An analysis of SR on UDR registered in the Rostov region in 2020 is conducted.

Publisher

Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency

Subject

General Medicine

Reference10 articles.

1. Glagolev S.V., Gorelov K.V., Chizhova D.A. Razvitie sistemy farmakonadzora v Rossijskoj Federacii [Development of the pharmacovigilance system in the Russian Federation]. Vestnik Roszdravnadzora [Bulletin of Roszdravnadzor]. 2019;(2):72–77. (In Russian).

2. Zhuravleva M.V., Romanov B.K., Gorodetskaya G.I., Muslimova O.V., Krysanova V.S., Demchenkova E. Yu. Aktual’nye voprosy bezopasnosti lekarstvennyh sredstv, vozmozhnosti sovershenstvovaniya sistemy farmakonadzora [Topical issues of drug safety, possibilities of improving of pharmacovigilance]. Bezopasnost’ i risk farmakoterapii [Safety and risk of pharmacotherapy]. 2019;7(3):109–119. (In Russian). DOI: 10.30895/2312-7821-2019-7-3-109-119.

3. Litvinenko T.S., Safronenko A.V., Gantsgorn E.V., Dyatchina L.I., Zamlelaya I.V., Myakota I.M., Bystrovskij V.O. Nezhelatel’nye pobochnye reakcii kak aktual’naya problema fundamental’noj i klinicheskoj farmakologii [Undesirable side reactions as an urgent problem of fundamental and clinical pharmacology]. Biomedicina [Journal Biomed]. 2020;16(3):115–119. (In Russian). DOI: 10.33647/2074-5982-16-3-115-119.

4. Shubnikova E.V., Darmostukova M.A., Bukatina T.M., Kaperko D.A., Velts N.Yu., Kazakov A.S., Snegireva I.I., Zhuravleva E.O., Kutekhova G.V. O zaregistrirovannyh v postmarketingovyj period nezhelatel’nyh reakciyah lekarstvennyh sredstv [The adverse drug reactions registered during the postmarketing period]. Bezopasnost’ i risk farmakoterapii [Safety and risk of pharmacotherapy]. 2019;7(1):15–22. (In Russian). DOI: 10.30895/2312-7821-2019-7-1-15-2.

5. Ahern F., Sahm L.J., Lynch D., McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: A cross-sectional study. Emerg. Med. J. 2014;31(1):24–29. DOI: 10.1136/emermed-2012-201945.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance: focus on the analysis of spontaneous reports of adverse drug reactions;South Russian Journal of Therapeutic Practice;2023-03-28